Fig. 8: Diverse kinase inhibitors activating GCN2 kinase increase its affinity for ATP. | Nature Communications

Fig. 8: Diverse kinase inhibitors activating GCN2 kinase increase its affinity for ATP.

From: Activation of the integrated stress response by inhibitors of its kinases

Fig. 8: Diverse kinase inhibitors activating GCN2 kinase increase its affinity for ATP.The alternative text for this image may have been generated using AI.

a–f In vitro kinase reactions with 7.5 nM GCN2 and indicated concentrations of ATP in presence of DMSO or compounds. a Ratio of active to total (active + inactive) GCN2 in the reactions with DMSO, 2.5 μM GSK’414 or 5 μM AMG44 fit to Michaelis-Menten nonlinear model. Data are shown as mean ± SD (DMSO n = 2, GSK’414 n = 3, AMG44 n = 4), biologically independent experiments. b Apparent affinity (Kobs) for GCN2 and ATP in presence of compounds from panel (a) normalised to DMSO. Data are shown as mean ± SD, biologically independent experiments. ***p < 0.0007, as determined by one-way ANOVA with Dunnett’s multiple comparison test. c As in panel (a) for reactions with DMSO or 0.75 μM C16 fit to Michaelis-Menten nonlinear model. Data are shown as mean ± SD (DMSO n = 3 and C16 n = 4, except 12 μM ATP n = 2 and n = 3 respectively), biologically independent experiments. d As in panel (b) for C16 normalised to DMSO. Data are shown as mean ± SD, biologically independent experiments. *p < 0.0231, as determined by two-sided, unpaired t-test. e As in panel (a) for reactions with DMSO, 2 μM Dovitinib or 1 μM Neratinib fit to Michaelis-Menten nonlinear model. Data are shown as mean ± SD (DMSO n = 2, Dovitinib n = 3, Neratinib n = 2), biologically independent experiments. f As in panel (b) for Dovitinib and Neratinib normalised to DMSO. Data are shown as mean ± SD, biologically independent experiments. **p < 0.0045, as determined by one-way ANOVA with Dunnett’s multiple comparison test. Source data are provided as a Source data file.

Back to article page